In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | -100% |
2012 | $0.14 M | -98.06% |
2011 | $7.58 M | -48.77% |
2010 | $14.8 M | -89.74% |
2009 | $0.14 B | 3046.71% |
2008 | $4.58 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | N/A | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | N/A | ๐บ๐ธ USA |